Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Income from Continuing Operations (2021 - 2026)

HeartSciences filings provide 6 years of Income from Continuing Operations readings, the most recent being 1990449.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 21.97% to 1990449.0 in Q1 2026 year-over-year; TTM through Jan 2026 was 8502444.0, a 1.73% increase, with the full-year FY2025 number at 8853024.0, down 32.93% from a year prior.
  • Income from Continuing Operations hit 1990449.0 in Q1 2026 for HeartSciences, up from 2352937.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1239354.0 in Q1 2022 to a low of 2550949.0 in Q1 2025.
  • Median Income from Continuing Operations over the past 5 years was 1900727.0 (2024), compared with a mean of 1854800.24.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 109.25% in 2022 and later grew 21.97% in 2026.
  • HeartSciences' Income from Continuing Operations stood at 1807710.0 in 2022, then grew by 3.28% to 1748381.0 in 2023, then fell by 20.26% to 2102631.0 in 2024, then decreased by 11.9% to 2352937.0 in 2025, then increased by 15.41% to 1990449.0 in 2026.
  • The last three reported values for Income from Continuing Operations were 1990449.0 (Q1 2026), 2352937.0 (Q4 2025), and 2057807.0 (Q3 2025) per Business Quant data.